•Reports circulated regarding a potential mega-merger between pharmaceutical giants AstraZeneca and Bristol Myers Squibb in a deal that could reach $400 billion.
•Financial analyst Jim Cramer expressed skepticism regarding the rumors, labeling the potential deal a 'fake out'.